# FDA Inspection 1099225 - Biomat USA, Inc - July 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e0709f3a-bd59-47de-bc16-da7280222dfa
Source feed: FDA_Inspections

> FDA Inspection 1099225 for Biomat USA, Inc on July 17, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099225
- Company Name: Biomat USA, Inc
- Inspection Date: 2019-07-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1020802 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ef35180a-4718-41f1-bc95-1127665db975)
- [FDA Inspection 928180 - 2015-05-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/33724dc4-0790-409a-b2a8-8f02097a6880)
- [FDA Inspection 840365 - 2013-07-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3174de7f-f9d9-4d49-80be-0a52fa0344d8)
- [FDA Inspection 728252 - 2011-06-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bf184435-96dc-4c39-8c7f-34ef59c261c9)
- [FDA Inspection 582367 - 2009-05-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3ba850cf-845a-4881-87b8-36d50993ad9a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/bf047d9d-6e74-4895-897e-e27bca0aa51c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d